CDODA-Me shows antineoplastic activity in bladder cancer cells by inducing ROS.
CDODA-Me down-regulates Sp and Sp-regulated proteins through ROS induction.
VEGFR2 is an important SP-1 target that was down-regulated by CDODA-Me.
CDODA-Me inhibits proliferation and induces apoptosis in tumor cells in vivo.